[Elsevier] Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial |
|
This post will be closed automatically in 2026-06-18 00:14
Reward10points
|
10
Exploring the anchoring effect of surface functionalized 2D electrides Ca2N and Y2C in lithium sulfur battery: First principle study
40
Urban flood modeling using hydrograph and Rain-on-Grid approaches with HEC-HMS and HEC-RAS: A case study of the Culiac芍n River
30
Modifying 2D surface models in urban flood analysis
10
pHLA-Bi-Mamba: A pan-specific deep learning model for peptide-HLA-i binding affinity and eluted ligand prediction
10
Drug-target interaction/affinity prediction: Deep learning models and advances review